Dr. Jannati shares groundbreaking insights into the integration of biomarkers and digital cognitive assessments to enable earlier and more accurate diagnoses of Alzheimer’s disease. He discusses the urgent need to equip primary care doctors with tools to identify mild cognitive impairment (MCI), a critical step in addressing cognitive decline before it progresses.
Discover how innovative approaches are transforming dementia science and bringing hope to millions affected by Alzheimer’s worldwide. Whether you’re a clinician, researcher, or advocate for better cognitive health, this episode is one you won’t want to miss.